These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9878876

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Central and peripheral actions of the NSAID ketoprofen on spinal cord nociceptive reflexes.
    Herrero JF, Parrado A, Cervero F.
    Neuropharmacology; 1997 Oct; 36(10):1425-31. PubMed ID: 9423930
    [Abstract] [Full Text] [Related]

  • 4. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF, Headley PM.
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [Abstract] [Full Text] [Related]

  • 5. Preclinical and clinical development of dexketoprofen.
    Mauleón D, Artigas R, García ML, Carganico G.
    Drugs; 1996 Sep; 52 Suppl 5():24-45; discussion 45-6. PubMed ID: 8922555
    [Abstract] [Full Text] [Related]

  • 6. Subanalgesic doses of dexketoprofen and HCT-2037 (nitrodexketoprofen) enhance fentanyl antinociception in monoarthritic rats.
    Gaitan G, Herrero JF.
    Pharmacol Biochem Behav; 2005 Feb; 80(2):327-32. PubMed ID: 15680185
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat.
    Thorn SA, Herrero JF, Headley PM.
    Brain Res; 1994 Nov 14; 663(2):352-6. PubMed ID: 7874523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of agmatine on spinal nociceptive reflexes: lack of interaction with alpha2-adrenoceptor or mu-opioid receptor mechanisms.
    Bradley KJ, Headley PM.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):133-8. PubMed ID: 9274971
    [Abstract] [Full Text] [Related]

  • 12. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG, West DC, Headley PM.
    Br J Pharmacol; 1989 Oct 23; 98(2):533-43. PubMed ID: 2555012
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. On the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat.
    Parsons CG, Headley PM.
    Br J Pharmacol; 1989 Oct 23; 98(2):544-51. PubMed ID: 2555013
    [Abstract] [Full Text] [Related]

  • 18. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
    Dong XW, Parsons CG, Headley PM.
    Br J Pharmacol; 1991 May 23; 103(1):1230-6. PubMed ID: 1652344
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.